Eric Shahinian - Sep 1, 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ Eric Shahinian
Stock symbol
KTTA
Transactions as of
Sep 1, 2022
Transactions value $
$100,367
Form type
4
Date filed
9/6/2022, 05:03 PM
Previous filing
Aug 31, 2022
Next filing
Sep 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $62.6K +55.6K +3.4% $1.13 1.69M Sep 1, 2022 See footnote F1
transaction KTTA Common Stock Purchase $13.1K +11.5K +0.68% $1.14 1.7M Sep 2, 2022 See footnote F1
transaction KTTA Common Stock Purchase $24.6K +21.7K +1.28% $1.13 1.72M Sep 6, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.